Sackler

In a 5-4 decision, the justices ruled that the multibillion opioid settlement inappropriately protected the Sackler family.

With a federal judge poised to approve Purdue Pharma's controversial Chapter 11 plan, the company is working behind the scenes to preempt a legal challenge by the Justice Department.

Judge Robert Drain signaled he will approve the landmark bankruptcy for Purdue Pharma, the maker of OxyContin. But he called for new limits to legal protections for members of the Sackler family.

Two divisions of the DOJ argue the deal improperly shelters members of the Sackler family and their associates from liability. States are finalizing a separate deal with other opioid companies.

Massachusetts and New York are among the states agreeing to end the fight to halt a controversial Purdue Pharma bankruptcy plan. The deal shelters members of the Sackler family from opioid lawsuits.

In a detailed memorandum, Attorney General Maura Healey alleges eight Sackler family members and nine Purdue board members or executives played key roles in the nation's deadly opioid epidemic.